Cargando…

Separating the direct effects of traits on atherosclerotic cardiovascular disease from those mediated by type 2 diabetes

AIMS/HYPOTHESIS: Type 2 diabetes and atherosclerotic CVD share many risk factors. This study aimed to systematically assess a broad range of continuous traits to separate their direct effects on coronary and peripheral artery disease from those mediated by type 2 diabetes. METHODS: Our main analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Walker, Venexia M., Vujkovic, Marijana, Carter, Alice R., Davies, Neil M., Udler, Miriam S., Levin, Michael G., Davey Smith, George, Voight, Benjamin F., Gaunt, Tom R., Damrauer, Scott M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960614/
https://www.ncbi.nlm.nih.gov/pubmed/35129650
http://dx.doi.org/10.1007/s00125-022-05653-1
_version_ 1784677415546519552
author Walker, Venexia M.
Vujkovic, Marijana
Carter, Alice R.
Davies, Neil M.
Udler, Miriam S.
Levin, Michael G.
Davey Smith, George
Voight, Benjamin F.
Gaunt, Tom R.
Damrauer, Scott M.
author_facet Walker, Venexia M.
Vujkovic, Marijana
Carter, Alice R.
Davies, Neil M.
Udler, Miriam S.
Levin, Michael G.
Davey Smith, George
Voight, Benjamin F.
Gaunt, Tom R.
Damrauer, Scott M.
author_sort Walker, Venexia M.
collection PubMed
description AIMS/HYPOTHESIS: Type 2 diabetes and atherosclerotic CVD share many risk factors. This study aimed to systematically assess a broad range of continuous traits to separate their direct effects on coronary and peripheral artery disease from those mediated by type 2 diabetes. METHODS: Our main analysis was a two-step Mendelian randomisation for mediation to quantify the extent to which the associations observed between continuous traits and liability to atherosclerotic CVD were mediated by liability to type 2 diabetes. To support this analysis, we performed several univariate Mendelian randomisation analyses to examine the associations between our continuous traits, liability to type 2 diabetes and liability to atherosclerotic CVD. RESULTS: Eight traits were eligible for the two-step Mendelian randomisation with liability to coronary artery disease as the outcome and we found similar direct and total effects in most cases. Exceptions included fasting insulin and hip circumference where the proportion mediated by liability to type 2 diabetes was estimated as 56% and 52%, respectively. Six traits were eligible for the analysis with liability to peripheral artery disease as the outcome. Again, we found limited evidence to support mediation by liability to type 2 diabetes for all traits apart from fasting insulin (proportion mediated: 70%). CONCLUSIONS/INTERPRETATION: Most traits were found to affect liability to atherosclerotic CVD independently of their relationship with liability to type 2 diabetes. These traits are therefore important for understanding atherosclerotic CVD risk regardless of an individual’s liability to type 2 diabetes. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00125-022-05653-1.
format Online
Article
Text
id pubmed-8960614
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-89606142022-04-07 Separating the direct effects of traits on atherosclerotic cardiovascular disease from those mediated by type 2 diabetes Walker, Venexia M. Vujkovic, Marijana Carter, Alice R. Davies, Neil M. Udler, Miriam S. Levin, Michael G. Davey Smith, George Voight, Benjamin F. Gaunt, Tom R. Damrauer, Scott M. Diabetologia Article AIMS/HYPOTHESIS: Type 2 diabetes and atherosclerotic CVD share many risk factors. This study aimed to systematically assess a broad range of continuous traits to separate their direct effects on coronary and peripheral artery disease from those mediated by type 2 diabetes. METHODS: Our main analysis was a two-step Mendelian randomisation for mediation to quantify the extent to which the associations observed between continuous traits and liability to atherosclerotic CVD were mediated by liability to type 2 diabetes. To support this analysis, we performed several univariate Mendelian randomisation analyses to examine the associations between our continuous traits, liability to type 2 diabetes and liability to atherosclerotic CVD. RESULTS: Eight traits were eligible for the two-step Mendelian randomisation with liability to coronary artery disease as the outcome and we found similar direct and total effects in most cases. Exceptions included fasting insulin and hip circumference where the proportion mediated by liability to type 2 diabetes was estimated as 56% and 52%, respectively. Six traits were eligible for the analysis with liability to peripheral artery disease as the outcome. Again, we found limited evidence to support mediation by liability to type 2 diabetes for all traits apart from fasting insulin (proportion mediated: 70%). CONCLUSIONS/INTERPRETATION: Most traits were found to affect liability to atherosclerotic CVD independently of their relationship with liability to type 2 diabetes. These traits are therefore important for understanding atherosclerotic CVD risk regardless of an individual’s liability to type 2 diabetes. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00125-022-05653-1. Springer Berlin Heidelberg 2022-02-07 2022 /pmc/articles/PMC8960614/ /pubmed/35129650 http://dx.doi.org/10.1007/s00125-022-05653-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Walker, Venexia M.
Vujkovic, Marijana
Carter, Alice R.
Davies, Neil M.
Udler, Miriam S.
Levin, Michael G.
Davey Smith, George
Voight, Benjamin F.
Gaunt, Tom R.
Damrauer, Scott M.
Separating the direct effects of traits on atherosclerotic cardiovascular disease from those mediated by type 2 diabetes
title Separating the direct effects of traits on atherosclerotic cardiovascular disease from those mediated by type 2 diabetes
title_full Separating the direct effects of traits on atherosclerotic cardiovascular disease from those mediated by type 2 diabetes
title_fullStr Separating the direct effects of traits on atherosclerotic cardiovascular disease from those mediated by type 2 diabetes
title_full_unstemmed Separating the direct effects of traits on atherosclerotic cardiovascular disease from those mediated by type 2 diabetes
title_short Separating the direct effects of traits on atherosclerotic cardiovascular disease from those mediated by type 2 diabetes
title_sort separating the direct effects of traits on atherosclerotic cardiovascular disease from those mediated by type 2 diabetes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960614/
https://www.ncbi.nlm.nih.gov/pubmed/35129650
http://dx.doi.org/10.1007/s00125-022-05653-1
work_keys_str_mv AT walkervenexiam separatingthedirecteffectsoftraitsonatheroscleroticcardiovasculardiseasefromthosemediatedbytype2diabetes
AT vujkovicmarijana separatingthedirecteffectsoftraitsonatheroscleroticcardiovasculardiseasefromthosemediatedbytype2diabetes
AT carteralicer separatingthedirecteffectsoftraitsonatheroscleroticcardiovasculardiseasefromthosemediatedbytype2diabetes
AT daviesneilm separatingthedirecteffectsoftraitsonatheroscleroticcardiovasculardiseasefromthosemediatedbytype2diabetes
AT udlermiriams separatingthedirecteffectsoftraitsonatheroscleroticcardiovasculardiseasefromthosemediatedbytype2diabetes
AT levinmichaelg separatingthedirecteffectsoftraitsonatheroscleroticcardiovasculardiseasefromthosemediatedbytype2diabetes
AT daveysmithgeorge separatingthedirecteffectsoftraitsonatheroscleroticcardiovasculardiseasefromthosemediatedbytype2diabetes
AT voightbenjaminf separatingthedirecteffectsoftraitsonatheroscleroticcardiovasculardiseasefromthosemediatedbytype2diabetes
AT gaunttomr separatingthedirecteffectsoftraitsonatheroscleroticcardiovasculardiseasefromthosemediatedbytype2diabetes
AT damrauerscottm separatingthedirecteffectsoftraitsonatheroscleroticcardiovasculardiseasefromthosemediatedbytype2diabetes